Literature DB >> 31477617

Reader response: Evidence in focus: Nusinersen use in spinal muscular atrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Jun-Ichi Takanashi1, Nanako Takase1.   

Abstract

Entities:  

Year:  2019        PMID： 31477617     DOI： 10.1212/WNL.0000000000008074

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

1.  The incidence of hydrocephalus among patients with and without spinal muscular atrophy (SMA): Results from a US electronic health records study.

Authors:  Ishir Bhan; Claudia Prada; Dayle James; Stacie Lallier; Anne Dilley; Susan Hall; Emma Viscidi; Nasha Wang; Maneesh Juneja; Corinne Makepeace; Karen Laird; Susan Eaton
Journal:  Orphanet J Rare Dis       Date:  2021-05-07       Impact factor: 4.123

Review 2.  Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders.

Authors:  Sibylle Jablonka; Luisa Hennlein; Michael Sendtner
Journal:  Neurol Res Pract       Date:  2022-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.